Navigation Links
Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association
Date:10/10/2007

WellPoint's PBM One of Only 13 Companies to Meet HRPA's Stringent Pricing

and Transparency Requirements

INDIANAPOLIS, Oct. 10 /PRNewswire/ -- WellPoint NextRx, the nation's largest health plan-owned pharmacy benefit management (PBM) subsidiary, has received Transparency in Pharmaceutical Purchasing Solutions (TIPPS) certification from the HR Policy Association (HRPA). Effective January 1, 2008, the certification will enable WellPoint NextRx to offer PBM services to customer members of the HRPA Pharmaceutical Purchasing Coalition, which is made up of more than 55 of the nation's largest employers and provides pharmacy benefits to more than five million Americans.

"WellPoint NextRx is committed to promoting transparency in our industry and our TIPPS certification is evidence of this commitment," said Renwyck Elder, president of WellPoint NextRx, a division of WellPoint, Inc. "We look forward to working with members of the HR Policy Association as well as other companies to help them better manage their pharmacy costs and develop benefit designs that bring the greatest possible value to their employees."

To be certified, WellPoint NextRx agreed to meet the following business standards:

-- To provide the acquisition price of brand and generic drugs

delivered by mail order

-- To charge employers the same price that WellPoint NextRx pays to the

dispensing pharmacy for brand and generic drugs dispensed at retail

pharmacies

-- To disclose and pass through any and all payments received by

WellPoint NextRx from pharmaceutical manufacturers that are based on

an employer's drug utilization

-- To allow an audit of contracts to verify compliance

Each year, the HRPA formulates a uniform definition of transparency and annually certifies organizations that agree to TIPPS standards. For 2008, HRPA has certified five new PBMs and recertified eight PBMs that have agreed to do business in a fully transparent manner.

"Full transparency makes it easier for employers, their employees, and their dependents to understand the true price of their medications to support more informative healthcare decisions," said Elder. "WellPoint NextRx has always been dedicated to full transparency and we are extremely proud that HRPA has recognized our efforts."

WellPoint NextRx is a service mark of WellPoint, Inc. (NYSE: WLP), services are provided by a WellPoint PBM (either Professional Claims Services Inc., doing business as WellPoint Pharmacy Management, or Anthem Prescription Management, LLC, as appropriate). WellPoint NextRx is a division of WellPoint, Inc.

About WellPoint, Inc.

WellPoint's mission is to improve the lives of the people it serves and the health of its communities. WellPoint, Inc. is the largest health benefits company in terms of commercial membership in the United States. Through its nationwide networks, the company delivers a number of leading health benefit solutions through a broad portfolio of integrated health care plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, pharmacy benefit management, dental, vision, behavioral health benefit services, as well as long term care insurance and flexible spending accounts. Headquartered in Indianapolis, Indiana, WellPoint is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Empire Blue Cross Blue Shield in 10 New York City metropolitan and surrounding counties and as Empire Blue Cross or Empire Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com.


'/>"/>
SOURCE WellPoint
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), ... labor and delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding ... the hospital and decide to donate. , “Women’s Hospital at Renaissance has been ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... of ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled ... wearable activity and sleep monitoring solutions for the global scientific community. The company’s ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
Breaking Medicine Technology: